SOFOSBUVIR IN THE LEAD


vertex_largeJust as I suspected, Gilead Science is going to be the big ticket winner in the race to kill the bug. Here’s an update on the field of competitors. The smart money says to buy some Gilead stock. I got in at $61 several weeks ago. 

Unknown's avatar

About asknod

VA claims blogger
This entry was posted in HCV Health, Medical News and tagged , , , , , , , , , , , , , , , . Bookmark the permalink.

Leave a comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.